Journal of Research and Development
Open Access
ISSN: 2311-3278
+44-77-2385-9429
ISSN: 2311-3278
+44-77-2385-9429
Anil Potdar, Chetan Gharat*, Kamlesh Patel and Nikhil Chougule
Background: Mobile-based health applications have significantly impacted patients' lives by reducing cardiovascular symptoms. This study evaluates the effectiveness of the Leading Your Future Experience (LYFE) app, a digital health intervention, when combined with Standard of Care (SOC) compared to SOC alone in post-Percutaneous Coronary Intervention (PCI) patients with Coronary Artery Disease (CAD) and/or Acute Coronary Syndrome (ACS).
Methods: This prospective, single-center, randomized controlled trial included 86 patients diagnosed with CAD or ACS who had undergone PCI. Participants were randomly assigned to either the LYFE group (n=42) or the SOC group (n=44). Outcomes were assessed at 1, 3, and 6 months, focusing on Quality of Life (QoL), medication adherence, physical activity, dietary adherence and biochemical parameters.
Results: The LYFE group demonstrated significantly greater improvements compared to the domains of the Dartmouth scale; including physical fitness (-2.0 vs. -0.9), feelings (-1.9 vs. -0.9), daily activities (-1.7 vs. -0.8), pain (-1.9 vs. -0.8), overall health (-1.9 vs. -0.6), and QoL (-1.8 vs. -0.6), (p<0.050). Adherence rates for lifestyle changes were significantly higher in the LYFE group, with 98.0% adhering to exercise and diet, compared to 47.4% and 50.0% in the SOC group, respectively. Medication adherence was also better, with 92.5% of LYFE patients rarely forgetting their medications, compared to 50.0% in the SOC group (p<0.050).
Conclusion: The integration of the LYFE app with SOC significantly enhances patient outcomes, including medication adherence, physical activity, and QoL, compared to SOC alone, and supporting value of digital health interventions in improving cardiovascular care.
Published Date: 2024-12-10; Received Date: 2024-11-08